Oncology Systems Limited

POWER SEARCH PRICING

SOLUTIONS

oncology systems limited Company Information

Live

MatureSmallDeclining

Company Number

03748527

Website

http://osl.uk.com

Registered Address

14 longbow professional centre, longbow close, shrewsbury, shropshire, SY1 3GZ

Industry

Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores

Telephone

01743462694

Next Accounts Due

January 2025

Group Structure

View All

Directors

Julie Mead25 Years

Carl Pavey25 Years

View All

Shareholders

julie mary mead 48.7%

carl robert pavey 42.5%

View All

oncology systems limited Estimated Valuation

£3.2m

Pomanda estimates the enterprise value of ONCOLOGY SYSTEMS LIMITED at £3.2m based on Net Assets of £1.3m and 2.44x industry multiple (adjusted for liquidity).

Edit your figures and get a professional valuation report.

Oncology Systems Limited AI Business Plan

In just minutes, we combine Pomanda’s company and industry data with cutting edge Artificial Intelligence to build a comprehensive 27 section business plan. You then have 60 days to tailor the information, decide which sections to include or exclude, and add your own branding logos, images and color scheme to create your perfect plan.

View Sample

Oncology Systems Limited is a live company located in shrewsbury, SY1 3GZ with a Companies House number of 03748527. It operates in the retail sale of medical and orthopaedic goods in specialised stores (not incl. hearing aids) n.e.c. sector, SIC Code 47749. Founded in April 1999, it's largest shareholder is julie mary mead with a 48.7% stake. Oncology Systems Limited is a mature, small sized company, Pomanda has estimated its turnover at £3.2m with declining growth in recent years.

View Sample

Upgrade for unlimited company reports & a free credit check

Pomanda's financial health check has awarded Oncology Systems Limited a 3 rating. We use a traffic light system to show it exceeds the industry average on 3 measures and has 7 areas for improvement. Company Health Check FAQs

Health Rating3out of 5

3 Strong

2 Regular

7 Weak

Size

annual sales of £3.2m, make it smaller than the average company (£11.4m)

Growth

3 year (CAGR) sales growth of -21%, show it is growing at a slower rate (6.7%)

Very Low Risk70 - 100

Low Risk50 - 70

Moderate Risk30 - 50

High Risk20 - 30

Very High Risk0 - 20

Get a comprehensive credit check for oncology systems limited. Get real-time insights into oncology systems limited's credit score, group structure and payment trends.

From as little as £6.99

This will not impact your credit rating!

View Credit Report Sample

Perform a competitor analysis for oncology systems limited by selecting its closest rivals and benchmarking them against 12 key performance metrics.

ONCOLOGY SYSTEMS LIMITED group structure

Oncology Systems Limited has no subsidiary companies.

Ultimate parent company

ONCOLOGY SYSTEMS LIMITED

03748527

ONCOLOGY SYSTEMS LIMITED Shareholders

julie mary mead	48.68%
carl robert pavey	42.48%
alice rose pavey	6.2%
carl douglas walker	2.63%

Oncology Systems Limited currently has 3 directors. The longest serving directors include Ms Julie Mead (Apr 1999) and Mr Carl Pavey (Apr 1999).

officer	country	age	start	end	role
Ms Julie Mead	United Kingdom	62 years	Apr 1999	-	Director
Mr Carl Pavey		68 years	Apr 1999	-	Director
Miss Alice Pavey		35 years	Mar 2023	-	Director

EXPORT

Oncology Systems Limited's latest turnover from April 2023 is estimated at £3.2 million and the company has net assets of £1.3 million. According to their latest financial statements, Oncology Systems Limited has 17 employees and maintains cash reserves of £812.1 thousand as reported in the balance sheet.

Data source: Companies House, Pomanda Estimates

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Turnover	3,209,512	2,757,739	2,884,704	6,610,423	4,689,736	3,720,166	4,562,881	4,319,183	5,350,798	8,874,798	8,334,725	9,825,531	9,360,065	9,038,926
Other Income Or Grants	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Cost Of Sales	1,905,977	1,670,353	1,838,736	4,301,759	3,064,797	2,437,144	2,694,251	2,544,023	3,096,890	5,590,898	5,325,270	5,582,404	5,461,065	5,115,374
Gross Profit	1,303,535	1,087,386	1,045,968	2,308,663	1,624,938	1,283,022	1,868,630	1,775,160	2,253,907	3,283,900	3,009,455	4,243,127	3,899,000	3,923,552
Admin Expenses	1,526,902	1,570,396	1,083,691	2,319,580	1,652,368	1,325,014	1,513,324	1,643,479	2,490,199	3,295,218	3,016,638	2,953,924	2,073,401	2,242,460
Operating Profit	-223,367	-483,010	-37,723	-10,917	-27,430	-41,992	355,306	131,681	-236,292	-11,318	-7,183	1,289,203	1,825,599	1,681,092
Interest Payable	0	0	0	0	0	0	0	0	0	0	0	60	60,066	59,130
Interest Receivable	53,956	12,745	1,608	1,567	13,028	8,631	2,977	4,280	6,274	12,088	13,865	0	0	0
Pre-Tax Profit	-169,411	-470,265	-36,115	-9,350	-14,402	-33,361	358,283	135,961	-230,018	771	6,682	1,292,584	1,765,533	1,621,962
Tax	0	0	0	0	0	0	-68,074	-27,192	0	-162	-1,537	-230,785	-471,758	-428,073
Profit After Tax	-169,411	-470,265	-36,115	-9,350	-14,402	-33,361	290,209	108,769	-230,018	609	5,145	1,061,799	1,293,775	1,193,889
Dividends Paid	0	0	0	0	0	0	0	0	0	0	0	780,000	1,250,001	1,080,000
Retained Profit	-169,411	-470,265	-36,115	-9,350	-14,402	-33,361	290,209	108,769	-230,018	609	5,145	281,799	43,774	113,889
Employee Costs	855,437	632,884	743,453	822,750	720,685	766,450	715,097	868,958	873,425	1,410,010	1,329,175	1,256,551	696,304	633,142
Number Of Employees	17	13	14	16	14	15	15	18	23	33	29	13	14	13
EBITDA*	-134,058	-375,618	67,689	98,546	83,677	59,034	824,918	426,232	-54,263	360,824	274,971	1,475,875	1,963,906	1,794,706

* Earnings Before Interest, Tax, Depreciation and Amortisation

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Tangible Assets	326,580	322,757	318,881	333,502	972,605	960,783	722,741	728,384	612,158	622,559	622,276	631,304	628,125	634,966
Intangible Assets	169,254	183,476	210,178	231,013	250,554	278,995	233,576	526,006	627,832	607,214	749,431	662,701	443,245	347,567
Investments & Other	767,000	657,500	657,500	646,907	0	0	0	0	0	0	0	0	0	0
Debtors (Due After 1 year)	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Fixed Assets	1,262,834	1,163,733	1,186,559	1,211,422	1,223,159	1,239,778	956,317	1,254,390	1,239,990	1,229,773	1,371,707	1,294,005	1,071,370	982,533
Stock & work in progress	196,309	218,292	145,605	155,021	105,378	97,254	142,166	159,605	147,549	119,150	103,432	87,091	96,115	123,174
Trade Debtors	581,313	611,928	470,333	1,712,697	1,238,736	842,007	1,060,545	1,033,292	947,252	1,313,030	844,065	1,369,777	1,078,260	1,070,383
Group Debtors	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Misc Debtors	216,225	48,577	11,357	11,145	29,829	24,033	155,368	65,120	0	0	0	41,542	107,743	0
Cash	812,123	1,726,975	1,671,796	1,544,509	1,590,263	1,883,952	1,568,587	812,889	899,286	1,610,285	3,225,091	2,320,709	2,306,897	1,356,904
misc current assets	0	0	0	0	0	0	0	0	0	0	0	0	0	0
total current assets	1,805,970	2,605,772	2,299,091	3,423,372	2,964,206	2,847,246	2,926,666	2,070,906	1,994,087	3,042,465	4,172,588	3,819,119	3,589,015	2,550,461
total assets	3,068,804	3,769,505	3,485,650	4,634,794	4,187,365	4,087,024	3,882,983	3,325,296	3,234,077	4,272,238	5,544,295	5,113,124	4,660,385	3,532,994
Bank overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Bank loan	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Trade Creditors	410,102	206,122	186,908	743,137	496,482	481,400	816,538	336,882	1,643,482	2,441,011	3,673,596	465,491	538,890	132,144
Group/Directors Accounts	495,608	1,177,225	490,440	830,172	587,704	306,758	574	347,439	0	0	0	1,627,765	1,398,824	556,056
other short term finances	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other current liabilities	789,093	951,817	905,451	1,100,942	1,129,573	1,307,867	1,006,746	853,118	0	0	0	1,166,480	1,195,335	1,387,504
total current liabilities	1,694,803	2,335,164	1,582,799	2,674,251	2,213,759	2,096,025	1,823,858	1,537,439	1,643,482	2,441,011	3,673,596	3,259,736	3,133,049	2,075,704
loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
hp & lease commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Accruals and Deferred Income	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
provisions	63,520	57,607	55,852	53,882	57,595	60,586	95,351	114,292	140,799	151,413	191,494	179,328	137,575	111,303
total long term liabilities	63,520	57,607	55,852	53,882	57,595	60,586	95,351	114,292	140,799	151,413	191,494	179,328	137,575	111,303
total liabilities	1,758,323	2,392,771	1,638,651	2,728,133	2,271,354	2,156,611	1,919,209	1,651,731	1,784,281	2,592,424	3,865,090	3,439,064	3,270,624	2,187,007
net assets	1,310,481	1,376,734	1,846,999	1,906,661	1,916,011	1,930,413	1,963,774	1,673,565	1,449,796	1,679,814	1,679,205	1,674,060	1,389,761	1,345,987
total shareholders funds	1,310,481	1,376,734	1,846,999	1,906,661	1,916,011	1,930,413	1,963,774	1,673,565	1,449,796	1,679,814	1,679,205	1,674,060	1,389,761	1,345,987

	Apr 2023	Apr 2022	Apr 2021	Apr 2020	Apr 2019	Apr 2018	Apr 2017	Apr 2016	Apr 2015	Apr 2014	Apr 2013	Apr 2012	Apr 2011	Apr 2010
Operating Activities
Operating Profit	-223,367	-483,010	-37,723	-10,917	-27,430	-41,992	355,306	131,681	-236,292	-11,318	-7,183	1,289,203	1,825,599	1,681,092
Depreciation	14,362	13,265	8,789	9,660	6,351	2,300	5,643	6,755	10,401	15,550	14,227	16,221	21,082	37,195
Amortisation	74,947	94,127	96,623	99,803	104,756	98,726	463,969	287,796	171,628	356,592	267,927	170,451	117,225	76,419
Tax	0	0	0	0	0	0	-68,074	-27,192	0	-162	-1,537	-230,785	-471,758	-428,073
Stock	-21,983	72,687	-9,416	49,643	8,124	-44,912	-17,439	12,056	28,399	15,718	16,341	-9,024	-27,059	123,174
Debtors	137,033	178,815	-1,242,152	455,277	402,525	-349,873	117,501	151,160	-365,778	468,965	-567,254	225,316	115,620	1,070,383
Creditors	203,980	19,214	-556,229	246,655	15,082	-335,138	479,656	-1,306,600	-797,529	-1,232,585	3,208,105	-73,399	406,746	132,144
Accruals and Deferred Income	-162,724	46,366	-195,491	-28,631	-178,294	301,121	153,628	853,118	0	0	-1,166,480	-28,855	-192,169	1,387,504
Deferred Taxes & Provisions	5,913	1,755	1,970	-3,713	-2,991	-34,765	-18,941	-26,507	-10,614	-40,081	12,166	41,753	26,272	111,303
Cash flow from operations	-201,939	-559,785	569,507	-192,063	-493,175	385,037	1,271,125	-244,165	-525,027	-1,396,687	2,878,138	968,297	1,644,436	1,804,027
Investing Activities
capital expenditure	-78,910	-84,566	-69,956	549,181	-94,488	-384,487	-171,539	-308,951	-192,246	-230,208	-359,856	-410,171	-227,144	-181,622
Change in Investments	109,500	0	10,593	646,907	0	0	0	0	0	0	0	0	0	0
cash flow from investments	-188,410	-84,566	-80,549	-97,726	-94,488	-384,487	-171,539	-308,951	-192,246	-230,208	-359,856	-410,171	-227,144	-181,622
Financing Activities
Bank loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Group/Directors Accounts	-681,617	686,785	-339,732	242,468	280,946	306,184	-346,865	347,439	0	0	-1,627,765	228,941	842,768	556,056
Other Short Term Loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Long term loans	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Hire Purchase and Lease Commitments	0	0	0	0	0	0	0	0	0	0	0	0	0	0
other long term liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0	0
share issue	103,158	0	-23,547	0	0	0	0	115,000	0	0	0	2,500	0	1,232,098
interest	53,956	12,745	1,608	1,567	13,028	8,631	2,977	4,280	6,274	12,088	13,865	-60	-60,066	-59,130
cash flow from financing	-524,503	699,530	-361,671	244,035	293,974	314,815	-343,888	466,719	6,274	12,088	-1,613,900	231,381	782,702	1,729,024
cash and cash equivalents
cash	-914,852	55,179	127,287	-45,754	-293,689	315,365	755,698	-86,397	-710,999	-1,614,806	904,382	13,812	949,993	1,356,904
overdraft	0	0	0	0	0	0	0	0	0	0	0	0	0	0
change in cash	-914,852	55,179	127,287	-45,754	-293,689	315,365	755,698	-86,397	-710,999	-1,614,806	904,382	13,812	949,993	1,356,904

P&L

April 2023

turnover

3.2m

+16%

operating profit

-223.4k

gross margin

40.7%

+3%

turnover

Turnover, or revenue, is the amount of sales generated by a company within the financial year.

Balance Sheet

April 2023

net assets

1.3m

-0.05%

total assets

3.1m

-0.19%

cash

812.1k

-0.53%

net assets

Total assets minus all liabilities

Similar Companies

Agree?

hitachi medical systems uk limited

sleep well enjoy life limited

2.5

integrated dna technologies uk, ltd

arden hemacare limited

kls martin uk limited

2.5

company number

03748527

Type

Private limited with Share Capital

industry

47749 - Retail sale of medical and orthopaedic goods (other than hearing aids) n.e.c., in specialised stores

incorporation date

April 1999

age

accounts

Total Exemption Full

ultimate parent company

None

previous names

N/A

incorporated

address

14 longbow professional centre, longbow close, shrewsbury, shropshire, SY1 3GZ

last accounts submitted

April 2023

A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.

We did not find charges/mortgages relating to oncology systems limited.

oncology systems limited Company Information

oncology systems limited Estimated Valuation

oncology systems limited Estimated Valuation

oncology systems limited Estimated Valuation

Oncology Systems Limited AI Business Plan

Oncology Systems Limited Overview

Oncology Systems Limited Health Check

oncology systems limited Credit Report and Business Information

Oncology Systems Limited Competitor Analysis

oncology systems limited Ownership

oncology systems limited directors

ONCOLOGY SYSTEMS LIMITED financials

oncology systems limited company details

oncology systems limited Charges & Mortgages

oncology systems limited Companies House Filings - See Documents